Treatment of systemic lupus erythematosus with bromocriptine

Abstract

Get full access to this article

View all access options for this article.

References

Walker SE . Bromocriptine treatment of systemic lupus erythematosus . Lupus 2001; 10: 762–768 .

Parkes D . Bromocriptine . New Engl J Med 1979; 301: 873–878 .

Miyasaki JM , Martin W , Suchowersky O , Weiner WJ , Lang AE . Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review . Neurology 2002; 58: 11–17 .

Rohmer V , Freneau E , Morange I , Simonetta C et al. Efficacy of quinagolide in resistance to ergot dopamine agonists: results of a multicenter study . Ann Endocrinol (Paris) 2000; 61 (5): 411–417 .

Sabuncu T , Arikan E , Tasan E , Hatemi H . Comparison of the effects of cabergoilne and bromocriptine on prolactin levels in hyperprolactinemic patients . Intern Med 2001; 40: 857–861 .

Reavill C , Jenner P , Marsden CD . Metabolite involvement in bromocriptine-induced circling behavior in rodents . J Pharm Pharmac 1980; 32: 278–284 .

Valente D , Delafonge M , Urien S , Guivarc'h D , Vient R , Grognet JM , Ezan E . Metabolite involvement in prolactin inhibition in rats . J Pharmac Exp Ther 1997; 282: 1418–1424 .

McMurray RW , Allen SH , Braun AL , Rodriguez F , Walker SE . Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease . J Rheumatol 1994; 21: 843–850 .

McMurray RW , Weidensaul D , Allen SH , Walker SE . Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus . J Rheumatol 1995; 22: 2084–2091 .

10.

Alvarez-Nemeguei J , Cobarrubias-Cobbs A , Escalante-Triay F , SosaMunoz J , Miranda JM , Jara LJ . Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study . Lupus 1998; 7: 414–419 .

11.

Funauchi M , Ikoma S , Enomoto H , Sugiyama M , Ohno M , Hamada K , Kanamaru A . Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma . Clin Exp Rheumatol 1998; 16: 479–482 .

12.

Walker SE , Reddy GH , Miller D et al. Treatment of active systemic lupus erythematosus (SLE) with the prolactin (PRL) lowering drug, bromocriptine (BC): comparison with hydroxychloroquine (HC) in a randomized, blinded one-year study . Arthritis Rheum 1999; 42: S282-S282 .

13.

Ben-Noun L . Drug-induced respiratory disorders: incidence, prevention and management . Drug Safety 2000; 23(2): 143–164 .

14.

Soares BGO , Lima MS , Reisser AAP , Farrell M . Dopamine agonists for cocaine dependence . Cochrane Database Syst Rev 2001; 4: CD003352-CD003352 .

15.

Greener J , Enderby P , Whurr R . Pharmacological treatment for aphasia following stroke . Cochrane Database Syst Rev 2001; 4: CD000424-CD000424 .

16.

Endocrinologic and Metabolic Drugs Advisory Committee . 70th Meeting, Bethesda, MD. Food and Drug Administration, 14 May, 1998. Meeting Transcript, p 135-135 .